Literature DB >> 26879730

[De-intensified chemoradiation therapy for favorable-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma].

R M Hermann1, H Christiansen2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26879730     DOI： 10.1007/s00066-016-0953-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  6 in total

1.  Human papillomavirus and survival of patients with oropharyngeal cancer.

Authors:  K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison
Journal:  N Engl J Med       Date:  2010-06-07       Impact factor: 91.245

Review 2.  [HPV-associated oropharyngeal carcinoma. Status quo and relationship with cancer of unknown primary].

Authors:  M Mollenhauer; G Assmann; P Zengel; O Guntinas-Lichius; S Ihrler
Journal:  Pathologe       Date:  2014-03       Impact factor: 1.011

3.  Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.

Authors:  Martina Buehrlen; Christian Michel Zwaan; Bernd Granzen; Lisa Lassay; Peter Deutz; Peter Vorwerk; Gundula Staatz; Günther Gademann; Hans Christiansen; Foppe Oldenburger; Miriam Tamm; Rolf Mertens
Journal:  Cancer       Date:  2012-02-22       Impact factor: 6.860

Review 4.  Lymph node positive head and neck carcinoma after curative radiochemotherapy: a long lasting debate on elective post-therapeutic neck dissections comes to a conclusion.

Authors:  R M Hermann; H Christiansen; R M Rödel
Journal:  Cancer Radiother       Date:  2013-05-23       Impact factor: 1.018

5.  Morbidity, mortality and cost from HPV-related oropharyngeal cancer: Impact of 2-, 4- and 9-valent vaccines.

Authors:  Greg Ward; Vikas Mehta; Michael Moore
Journal:  Hum Vaccin Immunother       Date:  2015-11-13       Impact factor: 3.452

6.  Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas.

Authors:  Hendrik Andreas Wolff; Ralph M W Rödel; Bastian Gunawan; Tobias Overbeck; Markus K A Herrmann; Steffen Hennies; Andrea Hille; Hilke Vorwerk; Christoph Matthias; Clemens F Hess; Hans Christiansen
Journal:  J Cancer Res Clin Oncol       Date:  2009-07-18       Impact factor: 4.553
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.